Protalix BioTherapeutics (PLX) Total Debt (QoQ) (2011 - 2024)
Protalix BioTherapeutics (PLX) Total Debt (QoQ) (2011 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Protalix BioTherapeutics | 190.95 Mn | 180.16 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.83% |
| Dec 31, 2023 | 0.29% |
| Sep 30, 2021 | -94.25% |
| Jun 30, 2021 | 1.78% |
| Mar 31, 2021 | 1.74% |
| Mar 31, 2018 | 0.15% |
| Dec 31, 2017 | -42.02% |
| Sep 30, 2017 | 137.43% |
| Jun 30, 2017 | 0.00% |
| Mar 31, 2017 | -92.61% |
| Dec 31, 2016 | 1,252.55% |
| Sep 30, 2016 | 0.00% |
| Jun 30, 2016 | 0.00% |
| Mar 31, 2016 | 0.00% |
| Jun 30, 2013 | -86.07% |
| Mar 31, 2013 | -50.23% |
| Dec 31, 2012 | 94.17% |
| Sep 30, 2012 | -40.30% |
| Dec 31, 2011 | 38.58% |